SR-12813

Research use only, not for human use.

SR-12813 is a pregnane X receptor (PXR) agonist.

SR-12813 is a pregnane X receptor (PXR) agonist.

SR-12813 inhibits incorporation of tritiated water into cholesterol with an IC50 of 1.2 μM but has no effect on fatty acid synthesis. Furthermore, SR-12813 reduces cellular 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity with an IC50 of 0.85 μM. Both 25-HC and SR-12813 can kill mammalian cells through blocking the synthesis of cholesterol, thereby they are ideal regents for lethal selection. SR-12813 kills HeLa cells at concentration range from 8 μM to 16 μM. SR-12813 kills wild type cells and mutant cells infected by Ad-Cre (SL-5+Cre), but the mutant SL-5 survives this condition. SR-12813 or 25-HC promotes the degradation of the 95-KDa full-length HMG-CoA reductase in wild type HeLa and SL-5 mutant cells.

——

GW 485801

Membrane Transporter/Ion Channel

Carbonic Anhydrase

HMG-CoA reductase

Metabolic Disease

——

126411-39-0

504.53

C24H42O7P2

>98% (HPLC)

DMSO : ≥ 50 mg/mL; 99.10 mM

CCOP(=O)(OCC)C(=CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C)P(=O)(OCC)OCC

——

(-20℃)

With Ice Pack

≥ 2 years